Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'. - Wikidata - awgldk - TriplyDB

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'.

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'.

http://www.wikidata.org/entity/Q34494216

about

Adaptive immunity in the liver Xenobiotics and loss of tolerance in primary biliary cholangitis Recent advances in the diagnosis and treatment of primary biliary cholangitis.Low-dose interleukin-2 promotes STAT-5 phosphorylation, Treg survival and CTLA-4-dependent function in autoimmune liver diseases Fibrates for the treatment of cholestatic itch (FITCH): study protocol for a randomized controlled trial.To screen or not to screen? Celiac antibodies in liver diseases.Fine-mapping analysis revealed complex pleiotropic effect and tissue-specific regulatory mechanism of TNFSF15 in primary biliary cholangitis, Crohn's disease and leprosy.Quantitation of the Rank-Rankl Axis in Primary Biliary Cholangitis.Evolving Trends in Female to Male Incidence and Male Mortality of Primary Biliary Cholangitis Protection against oxidative stress mediated by the Nrf2/Keap1 axis is impaired in Primary Biliary Cholangitis.Epidemiology and Natural History of Primary Biliary Cholangitis in the Chinese: A Territory-Based Study in Hong Kong between 2000 and 2015.It is time to change primary biliary cirrhosis (PBC): New nomenclature from "cirrhosis" to "cholangitis", and upcoming treatment based on unveiling pathology.Emerging drugs for the treatment of Primary Biliary Cholangitis.Incidence of Primary Biliary Cholangitis in a Rural Midwestern Population Systematic review: recurrent autoimmune liver diseases after liver transplantation.Non-invasive assessment of liver fibrosis using two-dimensional shear wave elastography in patients with autoimmune liver diseases Anti-mitochondrial M2 Antibodies Enhance the Risk of Supraventricular Arrhythmias in Patients with Elevated Hepatobiliary Enzyme Levels.A Randomized Trial of Obeticholic Acid Monotherapy in Patients with Primary Biliary Cholangitis.Primary biliary cholangitis: a comprehensive overview.The risk predictive values of UK-PBC and GLOBE scoring system in Chinese patients with primary biliary cholangitis: the additional effect of anti-gp210.Chronic Autoimmune Epithelitis in Sjögren's Syndrome and Primary Biliary Cholangitis: A Comprehensive Review.Equitable distribution in rare indications for liver transplantation: the dilemma of the too small tablecloth continues!Genetics and epigenetics in the pathogenesis of primary biliary cholangitis.Skin Manifestations Associated with Autoimmune Liver Diseases: a Systematic Review.Complications, symptoms, quality of life and pregnancy in cholestatic liver disease.Changing Nomenclature for PBC from "Primary Biliary Cirrhosis" to "Primary Biliary Cholangitis".Interferon-free treatment for patients with chronic hepatitis C and autoimmune liver disease: higher SVR rates with special precautions for deterioration of autoimmune hepatitis.Autoantibodies in Autoimmune Hepatitis: Can Epitopes Tell Us about the Etiology of the Disease?Toward solving the etiological mystery of primary biliary cholangitis.Morning Bright Light Treatment for Sleep-Wake Disturbances in Primary Biliary Cholangitis: A Pilot Study Anti-drug Antibodies Against a Novel Humanized Anti-CD20 Antibody Impair Its Therapeutic Effect on Primary Biliary Cholangitis in Human CD20- and FcγR-Expressing Mice

P2860

Q26753195-5353A174-8648-4688-84F6-6F02C17A1B16 Q26772312-67592B5C-8148-40AC-90F6-274D8088651A Q28076353-57F6AC0D-C352-4C27-AA0C-A31C4DCC721D Q33650813-332269B7-2067-4460-BEC4-1410497512CE Q33721771-7BBA781E-434C-41D0-82CF-5F1BDA892663 Q34551744-AF573A6C-2E2F-4333-B224-EBEEF41F55AD Q36099629-F94EBC4E-DCF2-4B19-B70D-30F57FF17580 Q36134061-0AC4FED0-52D8-42FF-946D-C6206B035F7C Q36914749-247EEED2-F191-4D4B-AC7A-FAB588FF1038 Q37717615-7F3AD143-C7E7-498D-8EA5-CC3DD4E1CDE5 Q38600118-F7542DBD-20F0-4FEA-B7D9-BCD0F01713D7 Q38620686-8DB0F03F-2294-43A7-B172-8160F4370A98 Q38744215-8869D54F-19E8-4318-8934-9DDA6A27A258 Q38795238-1ECF921C-CB34-43F4-AB09-1079DA117B43 Q39037242-A2DBFEAF-29F1-46EE-801D-AA2B9F8B3CFA Q41042363-4669D015-23BB-49DF-92B6-E4512ED0AE6A Q41307825-41A7FD92-C571-461D-BA66-9F4E1C6F412F Q45069872-1551D489-00A1-4357-85F1-F4D4B99BA509 Q46078221-0D86B486-04BA-42C7-96B5-A4756E86202E Q46813053-A326B0D7-66EF-4385-A7BF-8437B18583BC Q47146987-555DD452-5A2E-4C0A-A3DE-15FFA4740674 Q47341298-39D429CE-9F9C-4444-A95E-649FCE17B325 Q47827554-D09542D0-5D25-4F12-B586-CB1A0DFA8F8C Q48218731-279647FF-D5C4-47C1-ADF5-6527382ED895 Q48331749-DA8058D5-8E63-48CC-803A-D5344FE3C1EE Q50591717-07E67578-1237-4644-9C84-CE06BAFAA5F1 Q54254997-7165AC74-4ECF-4F11-805B-AFA68E14928F Q54939025-E1FAB406-00AB-4A20-91DD-FE508B373EA3 Q55387422-D1FD533D-26A6-4615-9C54-9FDA5071BF46 Q59136991-931067F3-80DB-4913-83E3-B318B4D0B2FF Q59137473-55606B30-3601-4A53-8068-93346281F69D

P2860

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'.

http://www.wikidata.org/entity/Q34494216

description

2015 nî lūn-bûn

@nan

2015 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'.

@ast

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'.

@en

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'.

@nl

type

label

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'.

@ast

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'.

@en

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'.

@nl

prefLabel

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'.

@ast

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'.

@en

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'.

@nl

P1433

Q34494216-83C4DA4D-49BB-4997-935E-3280C28CADEF

P1476

Q34494216-7D1AE0E8-4B48-4D5E-B45F-2EDA628C9E57

P2093

Q34494216-2F035795-CC99-4F48-9C31-06AD58E39343

Q34494216-41279F41-5784-419C-AE05-FD6440B5CD14

Q34494216-69C48446-C9E5-4426-9B75-417CCE8D3188

Q34494216-6A01C28A-285E-4ACD-A2E5-7E36B0C8E7DB

Q34494216-80E101BF-9F24-4560-8778-5D0DDB991F74

Q34494216-890DA263-DA4D-410D-98C7-580C84BF297A

Q34494216-BA5F045F-1387-4708-B9A5-9325EF6C95C5

Q34494216-BF4C1F63-357D-43DF-BD8B-CD2A6800F6D1

Q34494216-EC651FCE-304F-44E6-B88D-8E5A6E7BE9D5

P2860

Q34494216-00999935-4118-4C5B-AB7E-88A6D7C585BD

Q34494216-1D9FB97E-5564-4A31-9555-7ECCC5F1277E

Q34494216-1F60FDD7-03C5-437D-8F46-F99E911394ED

Q34494216-7985A9B4-B946-401C-91E4-943CEC94EC07

Q34494216-94A13BE8-9018-4FCD-98B9-4421E0075DD6

Q34494216-A14FC8C1-C71B-454A-854E-A7B1C6B6482C

Q34494216-B9DB7C34-C1CC-4254-B793-089E59B72E9E

Q34494216-BE9C9EC5-3FDA-491B-9C61-6EDD0D964692

Q34494216-C1FE3742-D935-4404-8384-442F933CCB42

Q34494216-D7F3E665-A298-4F2A-BDFE-C273500BC66C

P304

Q34494216-BE08EE9B-AA64-4E00-BC10-528B2E5860BE

P31

Q34494216-F89C35C3-3BBA-42A4-9A99-2CD825B209DB

P356

Q34494216-532FD58D-CD1D-403C-866A-E044A0ECCD0E

P407

Q34494216-BB37E8FD-D1CF-4022-8260-F8F729B3394E

P433

Q34494216-A0E9ADE3-5B5C-46F7-AE36-0C161917B94D

P478

Q34494216-389996FC-88E2-4B70-BBE6-A0798CC77BF6

P50

Q34494216-18EECEAD-E9DB-43AE-8E58-560A1066E077

Q34494216-30B3463B-2694-4C7D-9C4A-092D04F0BDBB

Q34494216-9EADC6F1-D342-4CA5-9B0F-C82031DDEFF4

P577

Q34494216-18415BEB-3F44-4F47-A6A4-3F073E6C573E

P5875

Q34494216-D3BD580A-C911-4A3F-A263-D6019F0DF729

P698

Q34494216-1D241011-6A86-43B0-A780-6FD3463D2167

P921

Q34494216-190D8781-3E5A-4000-9804-8AD566EF3B64

P356

P1433

P1476

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'.

@en

P2093

Albert Parés

http://www.w3.org/2001/XMLSchema#string

Atsushi Tanaka

http://www.w3.org/2001/XMLSchema#string

David E J Jones

http://www.w3.org/2001/XMLSchema#string

Ian R Mackay

http://www.w3.org/2001/XMLSchema#string

John M Vierling

http://www.w3.org/2001/XMLSchema#string

Keith Lindor

http://www.w3.org/2001/XMLSchema#string

Robert G Gish

http://www.w3.org/2001/XMLSchema#string

Ulrich Beuers

http://www.w3.org/2001/XMLSchema#string

Xiong Ma

http://www.w3.org/2001/XMLSchema#string

P2860

New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond

Up-regulation of microRNA 506 leads to decreased Cl-/HCO3- anion exchanger 2 expression in biliary epithelium of patients with primary biliary cirrhosis.

Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis

Role of cholangiocytes in primary biliary cirrhosis.

The immunobiology and pathophysiology of primary biliary cirrhosis.

The causes of primary biliary cirrhosis: Convenient and inconvenient truths.

The biliary HCO(3)(-) umbrella: a unifying hypothesis on pathogenetic and therapeutic aspects of fibrosing cholangiopathies.

Genetics and epigenetics of primary biliary cirrhosis.

Novel therapeutic targets in primary biliary cirrhosis.

A biliary HCO3- umbrella constitutes a protective mechanism against bile acid-induced injury in human cholangiocytes.

P304

1620-1622

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.28140

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

62

http://www.w3.org/2001/XMLSchema#string

P50

Pietro Invernizzi

M. Eric Gershwin

P577

2015-09-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282036086

http://www.w3.org/2001/XMLSchema#string

P698

26372460

http://www.w3.org/2001/XMLSchema#string

P921